YS
Aarti Drugs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cefixime | Anti-infective (Antibiotic) | Approved/Commercial |
| Azithromycin | Anti-infective (Antibiotic) | Approved/Commercial |
| Ofloxacin | Anti-infective (Antibiotic) | Approved/Commercial |
| Diclofenac Sodium | Anti-inflammatory, Analgesic | Approved/Commercial |
| Metformin HCl | Anti-diabetic | Approved/Commercial |
| Losartan Potassium | Cardiovascular (Hypertension) | Approved/Commercial |
| Pantoprazole Sodium | Gastrointestinal (Anti-ulcer) | Approved/Commercial |
| Steroids & Hormones Portfolio | Multiple (Dermatology, Hormone Therapy) | Approved/Commercial |
Leadership Team at Aarti Drugs
MM
Mukund M. Kothari
Whole-time Director
SS
Sushil S. Kothari
Whole-time Director
CS
Chandrakant S. Kothari
Whole-time Director
RG
Rajendra G. Kothari
Whole-time Director
SK
Sunil K. Jain
Chief Financial Officer
PV
Pravin V. Kulkarni
Company Secretary & Compliance Officer
AY
Anagha Y. Kothari
Independent Director
PN
Pradip N. Kothari
Independent Director
SS
Shailesh S. Vaidya
Independent Director
PM
Pramod M. Kothari
Independent Director